Towards tuberculosis elimination: an action framework for low-incidence countries

Knut Lönnroth(World Health Organization), Giovanni Battista Migliori(Fondazione Salvatore Maugeri), Ibrahim Abubakar(Public Health England), Lia D’Ambrosio(Fondazione Salvatore Maugeri), Gèrard de Vries(TuBerculosis Vaccine Initiative), Roland Diel(University Hospital Schleswig-Holstein), Paul Douglas, Dennis Falzon(World Health Organization), Marc-Andre Gaudreau(Public Health Agency of Canada), Delia Goletti, Edilberto González Ochoa(Instituto de Medicina Tropical “Pedro Kourí”), Philip LoBue(Centers for Disease Control and Prevention), Alberto Matteelli(World Health Organization), Howard Njoo(Public Health Agency of Canada), Ivan Solovič(Catholic University in Ruzomberok), Alistair Story, Tamara Tayeb(Ministry of Health), Marieke J. van der Werf(European Centre for Disease Prevention and Control), Diana Weil(World Health Organization), Jean-Pierre Zellweger, Mohamed Abdel Aziz(World Health Organization Regional Office for the Eastern Mediterranean), Mohamed R.M. Al Lawati(Ministry of Health), Stefano Aliberti(University of Milano-Bicocca), Wouter Arrázola de Oñate, Dráurio Barreira(Ministério da Saúde), Vineet Bhatia(World Health Organization), Francesco Blasi(University of Milan), Amy Bloom(United States Agency for International Development), Judith Bruchfeld(Karolinska University Hospital), Francesco Castelli(University of Brescia), Rosella Centis(Fondazione Salvatore Maugeri), Daniel Chemtob(Israel Ministry of Health), Daniela María Cirillo(Vita-Salute San Raffaele University), Alberto Colorado(Advocates for Youth), Andrei Dadu(World Health Organization Regional Office for Europe), Ulf R. Dahle(Norwegian Institute of Public Health), Laura De Paoli, Hannah Monica Dias(World Health Organization), Raquel Duarte(Direção Geral do Território), Lanfranco Fattorini(Istituto Superiore di Sanità), Mina Gaga(Ministry of Health), Haileyesus Getahun(World Health Organization), Philippe Glaziou(World Health Organization), Lasha Goguadze(International Federation of Red Cross and Red Crescent Societies), Mirtha del Granado(World Health Organization Regional Office for the Americas), Walter Haas(Robert Koch Institute), Asko Järvinen(Helsinki University Hospital), Geun‐Yong Kwon(Ministry of Health and Welfare), Davide Mosca(International Organization for Migration), Payam Nahid(University of California, San Francisco), Nobuyuki Nishikiori(World Health Organization Regional Office for the Western Pacific), Isabel Noguer(Instituto de Salud Carlos III), Joan O’Donnell(Health Protection Surveillance Centre), Analita Pace-Asciak(Ministry for Health), Maria Grazia Pompa(Ministero della Salute), G Popescu(Institutul de Pneumoftiziologie "Marius Nasta"), Carlos Robalo Cordeiro, Karin Rønning(Norwegian Institute of Public Health), Morten Rühwald(Statens Serum Institut), J.P. Sculier(Institut Jules Bordet), Aleksandar Šimunović(Hrvatski zavod za javno zdravstvo), Alison Smith‐Palmer(Health Protection Scotland), Giovanni Sotgiu(University of Sassari), Giorgia Sulis(World Health Organization), Carlos A. Torres‐Duque(Fundación Neumológica Colombiana), Kazunori Umeki(Ministry of Health Labour and Welfare), Mukund Uplekar(World Health Organization), Catharina Van Weezenbeek(TuBerculosis Vaccine Initiative), Tuula Vasankari(Finnish Lung Health Association), Robert J. Vitillo, Constantia Voniatis(Ministry of Health), Maryse Wanlin, Mario Raviǵlione(World Health Organization)
European Respiratory Journal
March 18, 2015
Cited by 771Open Access
Full Text

Abstract

This paper describes an action framework for countries with low tuberculosis (TB) incidence (<100 TB cases per million population) that are striving for TB elimination. The framework sets out priority interventions required for these countries to progress first towards "pre-elimination" (<10 cases per million) and eventually the elimination of TB as a public health problem (less than one case per million). TB epidemiology in most low-incidence countries is characterised by a low rate of transmission in the general population, occasional outbreaks, a majority of TB cases generated from progression of latent TB infection (LTBI) rather than local transmission, concentration to certain vulnerable and hard-to-reach risk groups, and challenges posed by cross-border migration. Common health system challenges are that political commitment, funding, clinical expertise and general awareness of TB diminishes as TB incidence falls. The framework presents a tailored response to these challenges, grouped into eight priority action areas: 1) ensure political commitment, funding and stewardship for planning and essential services; 2) address the most vulnerable and hard-to-reach groups; 3) address special needs of migrants and cross-border issues; 4) undertake screening for active TB and LTBI in TB contacts and selected high-risk groups, and provide appropriate treatment; 5) optimise the prevention and care of drug-resistant TB; 6) ensure continued surveillance, programme monitoring and evaluation and case-based data management; 7) invest in research and new tools; and 8) support global TB prevention, care and control. The overall approach needs to be multisectorial, focusing on equitable access to high-quality diagnosis and care, and on addressing the social determinants of TB. Because of increasing globalisation and population mobility, the response needs to have both national and global dimensions.


Related Papers

No related papers found

Powered by citation graph analysis